Rebecca M. Allen, MD, MPH is a Partner and the Director of Neuropsychiatry and Research at Seattle Neuropsychiatric Treatment Center (SeattleNTC). She is a graduate of Stanford University and Oregon Health and Science University School of Medicine, and she completed her residency at Harvard Longwood followed by Neuropsychiatry Fellowship at Brigham and Women's Hospital. Dr. Allen has held numerous leadership positions, most notably serving on the Executive Council of the Massachusetts Psychiatric Society (2015-17), as President of the Washington State Psychiatric Association (2020-21), and as President of the Clinical TMS Society (2023-24), in addition to roles at the American Psychiatric Association and chairing committees. Her practice specializes in Interventional Brain Medicine and has five locations in the northwest Washington area. Treatments offered include electroconvulsive therapy, transcranial magnetic stimulation, vagus nerve stimulation, esketamine, IV ketamine, and ketamine-assisted psychotherapy. She also serves as the site Principal Investigator for the research program at SeattleNTC, and studies have included psilocybin for treatment-resistant depression, oral medications for PTSD and depression, vagus nerve stimulation for unipolar and bipolar depression, and trials aiming to find biomarkers of response to treatment. She teaches residents from three local training programs and holds a faculty position of Clinical Assistant Professor at University of Washington.